Transcription of OFFICE-BASED BUPRENORPHINE THERAPY FOR …
{{id}} {{{paragraph}}}
BUPRENORPHINE -CONTAINING TRANSMUCOSAL PRODUCTS FOR THE TREATMENT OF OPIOID DEPENDENCE (BTOD)RISK EVALUATION AND MITIGATION STRATEGY (REMS) PROGRAMOFFICE- based BUPRENORPHINETHERAPY FOR OPIOID DEPENDENCE: IMPORTANT information FOR PHARMACISTSO ffice- based BUPRENORPHINE THERAPY for Opioid Dependence: Important information for PharmacistsTABLE OF CONTENTSS ection I. BTOD REMS ..p. 2 Section II. BUPRENORPHINE Product information Relevant to the REMS Goals ..p. 3 Section III. Highlighted Important Safety information for BUPRENORPHINE -containing Products.
Office-Based Buprenorphine Therapy for Opioid Dependence: Important Information for Pharmacists
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}